Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-04-20 Purchase | 2021-04-20 7:54 pm | Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy | 10,000 | $1.83 | $18,300 | 18,926 (Direct) | View |
| 2019-09-18 Sale(A) | 2019-10-15 5:08 pm | Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy | 1,350 | $1.7 | $2,295 | 8,926 (Direct) | View |
| 2019-09-18 Sale | 2019-09-23 5:09 pm | Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy | 1,350 | $1.7 | $2,295 | 80,863 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-20 Option Award | 2024-03-22 5:00 pm | N/A 2034-03-20 | Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CHIEF FINANCIAL OFFICER | 12,500 | $0 | 12,500 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 6:48 pm | N/A 2030-10-01 | Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy | 3,668,984 | $0 | 3,668,984 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 6:09 pm | N/A 2030-07-17 | Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy | 450,000 | $0 | 450,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-20 5:55 pm | N/A 2030-03-19 | Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy | 216,435 | $0 | 216,435 (Direct) | View |
| 2019-09-12 Option Award | 2019-09-13 5:04 pm | N/A 2029-09-12 | Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy | 450,000 | $0 | 450,000 (Direct) | View |